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BAM: A Block-Based Bayesian Method for Detecting Genome-Wide
Associations with Multiple Diseases
Guanying Wu, Xuan Guo , and Baohua Xu
Abstract: Many human diseases involve multiple genes in complex interactions. Large Genome-Wide Association
Studies (GWASs) have been considered to hold promise for unraveling such interactions. However, statistic tests
for high-order epistatic interactions (> 2 Single Nucleotide Polymorphisms (SNPs)) raise enormous computational
and analytical challenges. It is well known that the block-wise structure exists in the human genome due to Linkage
Disequilibrium (LD) between adjacent SNPs. In this paper, we propose a novel Bayesian method, named BAM, for
simultaneously partitioning SNPs into LD-blocks and detecting genome-wide multi-locus epistatic interactions that
are associated with multiple diseases. Experimental results on the simulated datasets demonstrate that BAM is
powerful and efficient. We also applied BAM on two GWAS datasets from WTCCC, i.e., Rheumatoid Arthritis and
Type 1 Diabetes, and accurately recovered the LD-block structure. Therefore, we believe that BAM is suitable and
efficient for the full-scale analysis of multi-disease-related interactions in GWASs.
Key words: disease association study; epistasis; Linkage Disequilibrium (LD) block; Bayesian methods
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Introduction

Most common diseases, such as hypertension, cancer,
diabetes, and heart disease, are resulting from the
joint effects of various genetic variants, environmental
factors, or their interactions. It is of great interest
to identify the genetic risk factors for understanding
disease mechanisms to develop effective treatments
and improve public health. Genome-Wide Association
Study (GWAS) has been proved to be a powerful
genomic and statistical inference tool to identify genetic
susceptibility on associations between traits of interests
and genetic information of unrelated individuals[1, 2] . In
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genetics, many genotype-phenotype association studies
have established that Single Nucleotide Polymorphisms
(SNPs)[3] , a common type of genetic variants, are
associated with a variety of diseases[4] . In a case-control
study, an SNP is said to be associated with a disease if the
genotype distributions at that SNP in cases and controls
are different. In addition to test SNPs individually, it
has been anticipated that epistatic interactions among
SNPs, defined as multiple SNPs jointly associated
with a disease, may be responsible for significantly
elevating the risks of some human complex diseases.
Moreover, there has been major progress in identifying
the genetic variants that influence a diverse range of
complex human phenotypes. These so-called pleiotropic
effects have been found in many diseases, including
cardiovascular disease[5, 6] , neurological disease[7–9] , and
psychiatric illness[10, 11] . In this paper, we consider
epistatic interactions as the statistically significant
associations of d genetic markers (d > 2) with multiple
phenotypes.
The problem of detecting high-order genome-wide
epistatic interactions using case-control data has
attracted extensive research interests recently. Many
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computational algorithms have been proposed. These
methods can be broadly grouped into three categories:
exhaustive search, stepwise search, and heuristic method.
Exhaustive search methods enumerate and test all SNPs
and their combinations under different statistical models,
such as 2 test, entropy-based test, and exact likelihood
ratio test[12–14] . Stepwise search methods avoid the
massive computation burden by selecting a subset of
SNPs or SNP combinations based on certain filtering
criteria, for example, low-order measurement tests,
then extending the SNP modules that pass criteria
to higher-order interactions[15, 16] . Heuristic methods
usually utilize machine learning techniques or stochastic
procedures to restrict the search space of interactions to
speed up the detection of genome-wide epistasis[17–19] .
More details about the popular GWAS mapping tools
can be found in recent surveys[20–24] . All these methods
are facing two fundamental challenges in detecting
genome-wide interactions related to multiple diseases:
the first arises from a heavy computational burden,
i.e., the number of tests grows exponentially as the
order of interaction goes up. For example, we need
to perform around 6:2511 statistical tests to detect
pairwise interactions for a moderate dataset with 500 000
SNPs. The second challenge is that existing methods
are not statistically powerful enough to test high-order
multi-locus models of multiple diseases. Because of an
enormous number of hypotheses with limited sample
size, a high proportion of significant associations is
expected to be false positives.
The current primary analysis paradigm for GWAS
is dominated by the analysis of the susceptibility of
SNPs to one disease a time, which might only explain
a small part of genetic causal effects and relations for
multiple complex diseases. Most current tools for highorder epistasis detection are only capable of identifying
interactions for GWAS data with two groups, i.e.,
case-control study, except for some recently developed
methods, such as SAM, a Jensen-Shannon-divergencebased method[25] , and DAM, a Bayesian inference
method for multi-locus associations[26] . A limitation
of DAM is the model assumes that a Markov chain
can capture the dependence structure of the SNPs in
the data. Linkage Disequilibrium (LD) is the wellknown dependence structure between adjacent SNPs
in the human genome[27–29] . Two loci are at LD if they
are non-randomly inherited, and they are at Linkage
Equilibrium (LE) if the inheritances are independent to
each other. One of the applications by applying LD in
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GWASs is the SNP tagging[30, 31] . An SNP is selected as
a tag SNP to represent a region of the genome if it is in
high LD with the group of SNPs in that region. Although
the SNP data from large GWASs are already using tag
SNPs to sample the genetic variants, it is inevitable to
have SNPs at strong LD. The LD between adjacent
SNPs exhibits a block-wise structure in the human
genome. SNPs within LD-blocks are highly correlated,
and the correlation is broken down by recombination
events at block boundaries. If some genuinely causal
SNPs are correlated with nearby SNPs due to the LD
effect, most popular association detecting tools would be
incapable of telling whether the significance is caused
by the interaction or the LD effect. A simple Markov
model used in DAM, therefore, cannot capture this block
structure when analyzing dense SNPs.
In this paper, we extend DAM to model the block
structures (referred as LD-block[32] ) and capture the
significant associations within and between the inferred
blocks. We name our novel method as BAM, Blockbased detection of genome-wide Association on Multiple
diseases. Experimental results on simulated datasets
demonstrate that BAM is capable of recovering perfectly
the LD-blocks and identifying complicated embedded
associations. We also applied BAM on two real WTCCC
datasets[33] , and some novel, interesting findings were
reported. The paper is organized as follows. In Section 2,
we present the extended Bayesian variable partition
model with the incorporation of the LD-block model. We
design a two-level Markov Chain Monte Carlo (MCMC)
updating scheme and a stepwise interaction evaluation
in Section 2.5. In Section 3, we demonstrate the superior
performance of BAM by simulation studies comparing
to two other approaches: DAM and SAM. We also report
the results by applying BAM to the Rheumatoid Arthritis
(RA) and Type 1 Diabetes (T1D) data from WTCCC.
We conclude the article in Section 4.

2
2.1

Materials and Methods
Notation

Suppose we have a GWAS dataset with M SNPs,
L traits, each trait with Nl samples (l 2 f1; 2; : : : ; Lg),
and total N samples. Let D denote an N  M matrix of
genotypes for all traits and samples, Di denote vectors of
genotypes observed at SNP i across samples and traits,
and D.i / denote an Ni  M matrix of genotypes for trait
i . Note that the superscript inside a pair of parentheses
is merely a label and does not represent the exponent.
As shown in Ref. [34], the number of partitions that
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a set of L traits can be separated into nonempty subsets
is a Bell number[35] . Let Q denote the set of distinct
partitions of L traits, Qi denote partition i , and Qi.j /
denote nonempty subset j in partition i. Each different
partition indicates a type of association that an SNP or
an SNP module may have with traits. Figure 1 shows
an example for a three-trait dataset with 10 association
types. For these association types, the first five indicate
SNPs are independently associated with traits, and
the rest five indicate SNPs are dependently associated
with traits. Given that SNPs can be independent or
dependent to other SNPs when associated with traits,
we have independent and dependent association types.
For simplicity, we use the same notation Qi to denote
association type i. When needed, we use QQ and QN
to distinguish independent and dependent association
types, respectively. Note that only association types
QN i ; i 2 f2; 3; 4; 5g, are epistatic interactions. Without
loss of generality, we always use Q1 to denote the
association type not associated with any disease trait.
The genotypes of m SNPs with association type Qi
.j /
in trait subset j are denoted by D.Q /i , which is an
Pl2Q.j /
NQ.j /  m matrix, where NQ.j / D l i Nl .
i
i
To model the LD effect, we seek to partition
the M SNPs into jBj consecutive blocks, where
B D fB1 ; B2 ; : : : ; BjBj g, and Bi is block i with jBi j
consecutive SNPs. The genotype defined by Bi is
denoted by DBi .
2.2

assumptions:
(1) Each SNP only belongs to one and only one LDblock.
(2) Each epistatic interaction contains two or more
than two SNPs, each of which is from different LDblock.
(3) In one LD-block, given the causal SNPs with
genotypes distributed differently between cases and
controls, the genotypes of the rest SNPs follow a
common distribution in both cases and controls.
2.3

Bayesian LD-block partition model

Here, we introduce a Bayesian LD-block partition
model for multiple traits without considering disease
association. For an LD-block Bk , there are 3jBk j possible
genotype combinations. Note that we use genotypes and
genotype combinations interchangeably. We assume that
the genotype combination g of each sample follows
independently from a multinomial distribution with
frequency parameters g , where g follows a Dirichlet
prior distribution with ˛g as a hyper-parameter (i.e.,
pseudo-counts). More precisely, with ng denoting the
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Illustration of ten association types in a dataset with three phenotypic traits.
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where ˛ı denotes the sum of values over all elements
in f˛g g. By integrating out fg g, we can obtain the
.Q

.j /

/

marginal probability of the data in DBk i as
Z
.j /
.j /
.Qi /
.Q /
P .DBk jBk / D P.DBk i jBk ; /P ./d D
Z

3jBk j

Y

.˛g /

jBk j
3Y

 ng C˛g

1

d D

 gD1

gD1

0

jBk j
3Y

@
gD1

1
.ng C˛g / A
.˛ı/

.˛g /
.NQ.j /C˛ı/
i

(1)
In our implementation, we set ˛g D

'

for every

3jBk j
genotype combination g, and let ' D 1:5. Note that
Eq. (1) can be used to model any Qi.j / with two or
more than two traits by counting genotypes across traits
in Qi.j / . Further assuming independence between LDblocks and independence between subsets of traits in a
partition, we obtain the probability function P .DjB/ of
genotypes of all LD-blocks, which is expressed as the
product of individual block probabilities as defined in
Eq. (1). For example, assume all LD-blocks with the
same association type Qi , then we have
0
1

Y Y  .Q.j / /
@ P D i jBk A :
P.DjB; Qi / D
Bk
k

2.4

The joint probability of the data in one LD-block can,
therefore, be expressed as
.Q1 /
.Q 1 /
.Q 1 /
P .DBk / D P .DB
jDB
/P .DB
/
(2)
k
k
k
where Q 1 denotes the association types other than
Q1 , and the genotypes with association types Q 1 are
denoted by D.Q 1 / . In each subset j of a partition of



.˛ı/
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j

Bayesian association inference based on LDblock partition model

The SNPs in an LD-block can be broadly categorized
into two groups: the SNPs truly associated with the
diseases, and the rest SNPs not associated with the
disease given the first group of SNPs. In this section, we
first propose a Bayesian model of disease associations
with only SNPs in one LD-block, and then extend it to
address epistatic interactions.
Based on our notations described in Section 2.1, we
know that the genotypes of SNPs with association types
Qi .i ¤ 1/ are truly associated with diseases, and the
genotypes of SNPs with association type Q1 are not
associated with diseases given D.Qi / . We can infer that
the genotypes D.Qi / .i ¤ 1/ are distributed differently
and are modeled by jQi j different distributions for each
subset of L traits in a partition. Conditional on the
genotypes of SNPs D.Qi / .i ¤ 1/, the genotypes of SNPs
in D.Q1 / follow a common distribution for each trait.

.Q

.j /

/

L traits, for each Qi 2 Q 1 , the genotypes DBk i
are modeled by a multinomial Dirichlet distribution as
specified in Eq. (1), and by assuming independence
between SNPs with different association types, we
obtain
0
1


.j /
Y
Y
.Q 1 /
@ P D.Qi / A :
P .DB
/D
Bk
k
j

i ¤1
.Q1 /
.Q
P .DB
jDB
k
k

1/

To model
/, we treat all SNPs with
association types Q 1 jointly and combine the
genotypes of SNPs with association type Q1 in all
cases and controls together. These genotypes are not
directly associated with any diseases given D.Q 1 / ,
and thus have the same conditional distributions in
cases and controls. Conditional on each possible
genotype combination of SNPs with association types
Q 1 , we model the conditional genotype combination
distribution of SNPs with association type Q1 again by
a multinomial-Dirichlet distribution. Thus, we derive
the following expression:
.Q1 /
.Q
P .DB
jDB
i
i

1/

/D

.Q1 ;Q
P .DB
i
.Q
P .DB
i

1 !Q1 /

1 !Q1 /

/

;

/

where Q 1 ! Q1 means temporally changing the
association types to Q1 for those SNPs originally with
Q 1 and changing back when we finish the probability
.Q 1 !Q1 /
calculation for P .DB
/.
i
To incorporate epistatic interactions in Eq. (2), we
model the SNPs with the same dependent association
type QN i to be jointly associated with the traits.
By assuming independence of SNPs with different
association types, we obtain
Y
N
N
P .D.Q/ / D
P .D.Qi / /;
N

i

where D.Qi / denotes the genotypes of the SNPs with
association type QN i across LD-blocks. We introduce a
latent M -dimensional indicator variable I to represent
the association types for M SNPs. Given a particular
block partition B and an association type indication I,
we obtain the joint probability function of the entire data
as

Tsinghua Science and Technology, October 2020, 25(5): 678–689

682
N

P .DjB; I/ D P .D.Q
Y

1/

smaller than log3 .N=10/ to avoid overfitting the blocks,
where N is the total number of samples in the data.
Note that the effects of the prior choices for B and I will
diminish as the sample size increases.

jB; I/
Qi/
.Q

P .Dl

jB; I/

Q i ;i¤1
lWIl DQ

Y

.Q1 /
.Q
P .DB
jDB
k
k

1/

; B; I/

(3)

k

Finally, the Bayesian association inference model
based on LD-block model for the data D, the block
variable B, and the association type indicator I is written
as
P .D; I; B/ D P .DjI; B/P .I/P .B/
(4)
where the conditional distribution P .DjI; B/ is
calculated in Eq. (3). We then obtain the posterior
distribution of I and B as
P .I; BjD/ / P .DjI; B/P .I/P .B/
(5)
The prior distribution of the association type
indicator I is set as a product of independent
Q Q jlWIl DQQ i j
multinomial distributions, P .I/ D jiQj

D1 Q
Qi
QjQj
N
N
jlWIl DQi j
, where QQ and QN denote the prior
i D1 Q
Ni
probability of each SNP belonging to independent
association type and dependent association type,
respectively. By default, we set QQ 1 D QN 1 D 5=M
P
P
and QQ 1 D QN 1 D .1 . i¤1 QQ i / . i ¤1 QN i //=2.
That is, we assume a priori that there are 5 SNPs
associated with diseases for each association type.
Increasing this prior may identify additional SNPs of
moderate to low effect sizes. We imposed a restriction
that the maximum number of SNPs with epistatic
association types must be smaller than log3 .N=10/
to avoid overfitting epistasis mapping. Similar to
the association type indicator vector I, the block
variable B in our model contains M binary indicators
corresponding to M SNPs. An element in B is equal
to 1 if the corresponding SNP is the start position of an
LD-block, and 0 otherwise. The prior distribution of the
block variable B is set as the product of jBj independent
Bernoulli probabilities P .B/ D jBj .1 /M jBj .
Based on the block distributions estimated in European
and Asian populations by Zhang et al.[32] and
Gabriel et al.[36] , we assume that there are 50 000
LD-blocks in the human genome, thus we set
 D 50 000=.3  109 / D 1:67  10 5 , where 3  109
is the length of the human genome. A smaller value
of  will result in less blocks with larger block size,
and a larger  will lead to identify more blocks with
smaller block size. We also imposed a restriction that
the maximum number of SNPs in an LD-block must be

2.5

MCMC sampling

We apply the Metropolis-Hastings (MH) algorithm[37]
to sample the indicators I and B from the distribution
defined by Eq. (5). According to the prior P .B/, we
first initialize B randomly, then use the MH algorithm to
construct an MCMC to update B. To explore all possible
LD-block partitions, we propose three MH updates: (1)
randomly select an LD-block and split it into two new
LD-blocks, (2) randomly select two adjacent LD-blocks
to merge into one LD-block, and (3) randomly select
two adjacent LD-blocks and shift their shared boundary
by a random position. In our implementation, we set
the three types of MH updates with probabilities 0.1,
0.1, and 0.8, respectively, and require each LD-block to
contain at least one SNP. The update is accepted based
on the MH ratio, which is a Gamma function. When
updating B, simultaneously, we use a method that mixes
the MH algorithm and a Gibbs sampler[38] to update the
association type indicator I. In each MCMC iteration,
a Gibbs sampler is used to update the association type
of each SNP by calculating the posterior distribution
Q Qg
N given all other model parameters and
of I D fQ;
the data. We also propose an MH update to switch the
association types of two SNPs and accept the update
based on MH ratios. In each MCMC iteration, we first
run the Gibbs sampler to update the association types
for all SNPs once, and then run the MH algorithm to
switch two SNPs with different association types. We
set a minimum threshold on the posterior probabilities
of I and use those SNPs with posterior probabilities
larger than the threshold as candidates in the interaction
evaluation process described in the next section.
2.6

Evaluation of epistasis interaction

With the candidate SNPs generated by MCMC, we
apply the 2 statistic and the conditional 2 test
to measure the significance for a module of SNPs.
Let A D .x1 ; : : : ; xd W Qi / denote an SNP module that
contains d SNPs with association type Qi . We use
2 .x1 ; : : : ; xd W Qi / to denote the 2 statistic of A
and 2 .x1 ; : : : ; xd jxc1 ; : : : ; xcd 0 W Qi / to denote the
conditional 2 statistic given a subset A0 D fxc1 ;
xc2 ; : : : ; xcd 0 g of A with d 0 SNPs. The 2 statistic is
calculated as
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2 .x1 ; : : : ; xd W Qi / D

jQi j 3d
XX

ej;g /2

.nj;g

j D1 gD1

ej;g

(6)

where nj;g denotes the frequency of genotype
combination g in a trait subset j , and ej;g denotes
the corresponding expected frequency of genotype
combination g. The degree of freedom for Eq. (6) is
.jQi j 1/  .3d 1/.
The conditional independent test based on the 2
statistic is defined as follows:
2 .x1 ; : : : ; xd jxc1 ; : : : ; xcd 0 W Qi / D
0

d d
3d jQ
i j 3X
X
X

0

./
.nj;g

D1 j D1 gD1

./ 2
ej;g
/
./
ej;g

(7)

0

The degree of freedom for Eq. (7) is 3d .jQi j 1/
0
.3d d
1/. We treat those SNPs as redundant SNPs
when they are conditionally independent by giving a
subset of the SNPs in one module. To avoid these
redundant SNPs, we define an SNP module (d > 2)
as a compact, significant epistatic interaction by the
following definition.
Definition 1 An SNP module A D .x1 ; : : : ; xd W Qi /
is considered as a significant, compact epistatic
interaction by giving a significant level ˛d , if it meets
the following three conditions:
(1) the p-value of 2 .x1 ; : : : ; xd W Qi / D the minimum
p-value of 2 .x1 ; : : : ; xd W Q/, 8Qi ;
(2) the p-value of 2 .x1 ; : : : ; xd W Qi / 6 ˛d ;
(3) the p-value of 2 .x1 ; : : : ; xd jxc1 ; : : : ; xcd 0 W Qi / 6
˛d , for 8A0 D fxc1 ; : : : ; xcd 0 g.
Based on Definition 1, we develop a stepwise
procedure to search top-f d -locus significant, compact
interactions, where the search space only includes the
SNPs yielded by MCMC sampling. Here, f is a userdefined number. We restrict that each SNP can only
present in one significant, compact interaction. We
first search all the modules with just one SNP based
on Definition 1. All SNPs with significant marginal
associations after a Bonferroni correction are reported
in a list L. And then, we recursively test all the possible
combinations of SNPs in L by increasing the module
size by one at a time until the module size reaches a user
pre-set value. Bonferroni correction is applied to both
independent associations and epistatic associations.

3

Experiment and Result

To show the performance of BAM with consideration
of LD effects, we first introduce the simulation using
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HapMap data[39] . We use the null simulation to test
the Type I error rate of BAM. We compared BAM to
two other methods (i.e., DAM[26, 34] and SAM[25] ) that
can find epistatic interactions associated with multiple
diseases. In this comparison, we use a set of simulated
datasets in which four types of known disease-specific
associations were embedded in each dataset. We also
apply BAM to two real WTCCC datasets, RA and T1D,
and BAM produced accurate block partitions that match
well to the visual blocks displayed by Haploview[40] .
3.1

Experimental design

Data simulation: To evaluate the effectiveness of
BAM, we performed extensive simulation experiments
using four disease models of two-locus associations.
We set the number of traits to be three. The sample
sizes for three traits were set to .800; 800; 800/ or
.1600; 1600; 1600/, where we consider the first two
groups as the case groups and the third one as the control
group. As the example shown in Fig. 1, we have ten
different association types, and four of them are epistatic
interactions associated with diseases. We labeled these
four types of epistatic interactions as QN 2 , QN 3 , QN 4 , and
QN 5 . We used four disease models (Table 1) to simulate
epistatic interactions. These four disease models are
identical to the first four models in Ref. [26]. QN 2 , QN 3 ,
and QN 4 only need one disease model to simulate epistatic
interactions since we only need two different genotype
distributions. QN 5 needs three distributions, thus we use
four pairs of models (i.e., Models 1 & 2, Models 2 & 3,
Models 3 & 4, and Models 4 & 1) to simulate epistatic
interactions for QN 5 . For each epistatic interaction, we
varied the Minor Allele Frequency (MAF) ranged in
Table 1

Model 1

Model 2

Model 3

Model 4

Odds tables of disease Models 1 – 4.
BB
Bb
bb
AA



Aa

.1 C /
.1 C /2
aa

.1 C /2
.1 C /4
AA

.1 C /
.1 C /
Aa
.1 C /


aa
.1 C /


AA


.1 C /
Aa

.1 C /

aa
.1 C /


AA

.1 C /

Aa
.1 C /

.1 C /
aa

.1 C /


Note: The disease prevalence p.D/, the genetic heritability
h2 , and the MAFs determine the parameters ( and  ) as in
Ref. [41]. In the simulation, we set p.D/ D 0:1 for all models,
h2 D 0:03 for Model 1, h2 D 0:02 for Models 2 – 4, and the
MAFs of disease-associated SNPs to be 0.1, 0.2, and 0.4.

3.2

Null simulation to test Type I errors

To evaluate the Type I errors of BAM, we conducted
the null simulation experiments. We simulated 1000
datasets without disease association embedded. The
false-positive rate of BAM is shown in Fig. 2. By setting
the significance level to 0.1, BAM always obtained low
false-positive rates under the different sample sizes and
the numbers of SNPs. Under most of the situations,
BAM did not report any significant interaction. For the
situations with zero false-positive rate, we found that
there is no significant association with the posterior
probability larger than the threshold 0.5.
3.3

Simulation experiments for four epistatic
association types

To verify the effectiveness of BAM, we used
the simulation strategy introduced in Section 3.1,
where the LD-block structure is from a real human
genome. Although the detailed boundary information is
unavailable, the block structure widely exists across the
entire human genome. The performance comparison
between BAM, DAM, and SAM is shown in Fig. 3.
We can find that BAM achieves better performance

d=2
d=3
d=4

0.0008

False-positive rate

f0:1; 0:2; 0:4g. We generated 100 replicas per MAF
setting. Note that there are only three types of epistatic
interactions for QN 5 when MAF D 0:1, because the other
model pairs do not have feasible solutions for  and .
In total, we generated 92 epistatic interactions. Each
simulation replica contained M D 1000 SNPs and an
epistatic interaction of two SNPs. To mimic real genetic
data in human populations, we select an arbitrary region
in Chromosome 22. Given the genotypes of two SNPs
in an epistatic interaction, we randomly sampled up to
4800 individuals from a pool of controls generate by
HAPGEN[42] using HapMap European samples[39] with
odds ratio D 1. The genotypes of unassociated SNPs
are sampled from that control pool with the ordering of
these SNPs kept the same as in Chromosome 22. We
applied a quality control procedure by removing SNPs
with MAF < 0:05 or p-values less than 0.001 from the
Hardy-Weinberg Equilibrium test.
Statistical power: In the evaluation of performances
on simulated data, for each setting, we generated 100
datasets, each of which contains one epistatic interaction.
We define the measurement of discrimination power as
the fraction of 100 datasets on which the ground-truth
epistatic interactions are ranked as the top one and passed
the significance threshold by the method of interest.
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Fig. 2 False-positive rates of BAM under null models. The
plots in (a) and (b) show the false-positive rates of BAM for
different d when the sample sizes and the numbers of SNPs
vary. In (a), N1 D f200, 200, 400g, N2 D f400, 400, 800g, N3 D
f800, 800, 1600g, and N4 D f1600, 1600, 3200g.

when sample size increases from 2400 to 4800. For
Models 1 & 3, BAM had steady power regardless of
MAF. For Models 2 & 4, the power of BAM decreased
as MAF increased. By examining the composition of
heritability of these four models that also used in Ref.
[26], we found that Models 2 & 4 have the same
amount of heritability, but the main effects decrease
as MAF goes up. Thus, the performance of BAM is
positively related to the amount of main effects in the
epistatic interactions. For interaction QN 5 that has distinct
effects on each trait, BAM obtained higher power than
the other two methods regardless of the sample size.
To show the overall performance for all four epistasis
types, we used a metric called overall quality introduced
in Ref. [26] to evaluate the overall performance of
these three methods. The overall quality is defined by
ncorrect =ntotal , where ncorrect is the number of datasets
where the method successfully detects the ground-truth
interaction and ntotal is the total number of datasets. The
overall qualities of BAM, SAM, and DAM are 0.564,
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Fig. 3 Performance comparison between BAM, SAM, and DAM on the datasets with two-locus epistatic interactions. The
x-axis shows the MAF value.
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0.283, and 0.119 for the datasets with 2400 individuals,
and 0.742, 0.663, and 0.321 for the datasets with 4800
individuals, respectively. Compared to DAM, BAM
showed greatly power improvement with LD effects into
consideration. We also found that SAM performed better
than DAM when LD-block structures existed. When
comparing the candidate SNP lists generated by SAM
and DAM, we found that DAM had difficulty to select
the disease-associated SNPs in the blocks. In contrast,
SAM uses a clustering algorithm to group SNPs with
different genotype distributions in different traits. So,
SAM tends to place causal SNPs and their nearby SNPs
into different clusters, and the disease-associated SNPs
may have a chance to be evaluated in the following tests.
3.4

Experiments on the WTCCC data

We also applied BAM to two real GWAS datasets (i.e.,
RA and T1D) to examine the performance of BAM on
LD-block structure estimation. Here, we focused on
the results from Chromosome 6. The block structures
due to LD effects have many different definitions. To
give an intuitive idea of the performance of the block
structure yielded by BAM, we randomly selected four
regions with lengths about 200 kb and used HapMap
to draw the corresponding Haploviews of these regions.
Figure 4 shows the recovered block structures by BAM
and the corresponding Haploviews. We set the number
of iterations to 300 with an extra 300 in the burn-in
process. Comparing to the visual blocks from Haploview,
BAM produced relatively accurate LD-block partitions
for these four regions.
3.5

Computational efficiency

We used two simulation datasets to evaluate the
performance of computation time for BAM. Both
datasets contain three traits, each with 2000 samples.
The first dataset comprises 1000 SNPs, and the
second one comprises 104 SNPs. The experiments were
conducted on a Unix system powered by 2.60 GHz
Intel Xeon Silver 4112 with 32 GB RAM. We run the
ten independent MCMC chains for each dataset. The
averaged computation time of 10 chains are 14 minutes
and 10 hours, with the numbers of iteration set to 106
and 107 for these two datasets, respectively. Similar to
DAM, BAM uses the boolean representation introduced
by Wan et al.[12] BAM used about 21 MB memory for
the second dataset. The memory usage of BAM is linear
to the number of SNPs and sample size. For a typical
GWAS dataset with 5105 SNPs and 6000 samples,
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the estimation of memory consumption is around 1 GB.
Therefore, memory is not a problem for BAM, given the
current popular hardware configuration.

4

Conclusion

In this paper, we proposed a block-based Bayesian
method, called BAM, for LD-block inference and
detection of high-order epistatic interaction on multiple
diseases. Extensive experimental results on simulated
datasets indicate that BAM can identify embedded
disease associations even with block structures present.
By comparing to two other methods, i.e., SAM and
DAM, we showed that BAM substantially improved the
statistical power by incorporating the LD model to the
Bayesian inference model. The results from experiments
in human Chromosome 6 showed that BAM is capable
of recovering the block structures accurately.
When using BAM on real data, we suggest applying
the quality control procedures as presented in other
recent studies[41, 43] because sequencing bias and
genotyping bias could confound BAM and lead to
false-positive disease-related SNPs. For example, the
coverage bias that is caused by the sequencing platforms
may generate SNPs with low, uneven coverage between
case and control groups. Quality control is necessary
to remove those unreliable SNPs. Other issues, such
as the branch effects across multiple studies, may lead
to population stratification that causes the p-values
of disease-unrelated SNPs inflated[44] . Therefore, in
addition to BAM, we suggest employing other methods,
such as those based on linear mixed model, to adjust the
p-value of reported SNPs by BAM.
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U. Võsa, S. de Jong, M. R. Robinson, et al., Genomewide association analyses identify new risk variants and the
genetic architecture of amyotrophic lateral sclerosis, Nature
Genetics, vol. 48, no. 9, p. 1043, 2016.
S. Ripke, N. R. Wray, C. M. Lewis, S. P. Hamilton, M. M.
Weissman, G. Breen, E. M. Byrne, D. H. Blackwood, D. I.
Boomsma, S. Cichon, et al., A mega-analysis of genomewide association studies for major depressive disorder,
Molecular Psychiatry, vol. 18, no. 4, p. 497, 2013.
P. Sklar, S. Ripke, L. J. Scott, O. A. Andreassen, S. Cichon,
N. Craddock, H. J. Edenberg, J. I. Nurnberger, M. Rietschel,
D. Blackwood, et al., Large-scale genome-wide association
analysis of bipolar disorder identifies a new susceptibility
locus near ODZ4, Nature Genetics, vol. 44, no. 9, p. 1072,
2012.
X. Wan, C. Yang, Q. Yang, H. Xue, N. L. Tang, and W. Yu,
Detecting two-locus associations allowing for interactions
in genome-wide association studies, Bioinformatics, vol. 26,
no. 20, pp. 2517–2525, 2010.
L. S. Yung, C. Yang, X. Wan, and W. Yu, Gboost: A GPUbased tool for detecting gene–gene interactions in genome–
wide case control studies, Bioinformatics, vol. 27, no. 9,
pp. 1309–1310, 2011.
Y. Liu, H. Xu, S. Chen, X. Chen, Z. Zhang, Z. Zhu,
X. Qin, L. Hu, J. Zhu, G. P. Zhao, et al., Genome-wide
interaction-based association analysis identified multiple
new susceptibility loci for common diseases, PLoS
Genetics, vol. 7, no. 3, p. e1001338, 2011.
J. Marchini, P. Donnelly, and L. R. Cardon, Genome-wide
strategies for detecting multiple loci that influence complex
diseases, Nature Genetics, vol. 37, no. 4, p. 413, 2005.
J. Li, A novel strategy for detecting multiple loci in genomewide association studies of complex diseases, International
Journal of Bioinformatics Research and Applications, vol. 4,
no. 2, p. 150, 2008.
X. Wan, C. Yang, Q. Yang, H. Xue, N. L. Tang, and W. Yu,
Predictive rule inference for epistatic interaction detection
in genome-wide association studies, Bioinformatics, vol. 26,
no. 1, pp. 30–37, 2009.
B. Liu, S. Feng, X. Guo, and J. Zhang, Bayesian analysis
of complex mutations in hbv, hcv, and hiv studies, Big Data
Mining and Analytics, vol. 2, no. 3, pp. 145–158, 2019.
Y. Zhang and J. S. Liu, Bayesian inference of epistatic
interactions in case-control studies, Nature Genetics,
vol. 39, no. 9, p. 1167, 2007.
X. Guo, N. Yu, F. Gu, X. Ding, J. Wang, and Y. Pan,
Genome-wide interaction-based association of human
diseases—a survey, Tsinghua Science and Technology,
vol. 19, no. 6, pp. 596–616, 2014.
P. M. Visscher, N. R. Wray, Q. Zhang, P. Sklar, M. I.

Tsinghua Science and Technology, October 2020, 25(5): 678–689

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

McCarthy, M. A. Brown, and J. Yang, 10 years of GWAS
discovery: Biology, function, and translation, The American
Journal of Human Genetics, vol. 101, no. 1, pp. 5–22, 2017.
C. Niel, C. Sinoquet, C. Dina, and G. Rocheleau, A survey
about methods dedicated to epistasis detection, Frontiers in
Genetics, vol. 6, p. 285, 2015.
Y. J. Wen, H. Zhang, Y. L. Ni, B. Huang, J. Zhang, J. Y.
Feng, S. B. Wang, J. M. Dunwell, Y. M. Zhang, and R. Wu,
Methodological implementation of mixed linear models in
multi-locus genome-wide association studies, Briefings in
Bioinformatics, vol. 19, no. 4, pp. 700–712, 2017.
X. Ding and X. Guo, A survey of SNP data analysis, Big
Data Mining and Analytics, vol. 1, no. 3, pp. 173–190,
2018.
X. Guo, Searching genome-wide disease association
through SNP data, PhD dissertation, Georgia State
University, Athens, GA, USA, 2015.
X. Guo, J. Zhang, Z. Cai, D. Z. Du, and Y. Pan, Searching
genome-wide multi-locus associations for multiple diseases
based on bayesian inference, IEEE/ACM Transactions on
Computational Biology and Bioinformatics , vol. 14, no. 3,
pp. 600–610, 2017.
T. Berisa and J. K. Pickrell, Approximately independent
linkage disequilibrium blocks in human populations,
Bioinformatics, vol. 32, no. 2, p. 283, 2016.
S. Gazal, H. K. Finucane, N. A. Furlotte, P. R. Loh, P. F.
Palamara, X. Liu, A. Schoech, B. Bulik-Sullivan, B. M.
Neale, A. Gusev, et al., Linkage disequilibrium–dependent
architecture of human complex traits shows action of
negative selection, Nature Genetics, vol. 49, no. 10, p. 1421,
2017.
Y. Cheng, H. Sabaa, Z. Cai, R. Goebel, and G. Lin, Efficient
haplotype inference algorithms in one whole genome
scan for pedigree data with non-genotyped founders, Acta
Mathematicae Applicatae Sinica, English Series, vol. 25,
no. 3, pp. 477–488, 2009.
Z. Liu and S. Lin, Multilocus LD measure and tagging SNP
selection with generalized mutual information, Genetic
Epidemiology: The Official Publication of the International
Genetic Epidemiology Society, vol. 29, no. 4, pp. 353–364,
2005.
Z. Cai, H. Sabaa, Y. Wang, R. Goebel, Z. Wang, J. Xu,
P. Stothard, and G. Lin, Most parsimonious haplotype allele
sharing determination, BMC Bioinformatics, vol. 10, no. 1,
p. 115, 2009.
Y. Zhang, J. Zhang, and J. S. Liu, Block-based bayesian
epistasis association mapping with application to WTCCC
type 1 diabetes data, The Annals of Applied Statistics, vol. 5,
no. 3, p. 2052, 2011.
Wellcome Trust Case Control Consortium, Genome-wide
association study of 14 000 cases of seven common diseases
and 3000 shared controls, Nature, vol. 447, no. 7145, p. 661,
2007.
X. Guo, J. Zhang, Z. Cai, D. Z. Du, and Y. Pan, DAM: A
bayesian method for detecting genome-wide associations
on multiple diseases, in Bioinformatics Research and
Applications. New York, NY, USA: Springer, 2015, pp. 96–
107.

Guanying Wu et al.: BAM: A Block-Based Bayesian Method for Detecting Genome-Wide Associations : : :

689

[35] E. T. Bell, Exponential numbers, The American
Mathematical Monthly, vol. 41, no. 7, pp. 411–419, 1934.
[36] S. B. Gabriel, S. F. Schaffner, H. Nguyen, J. M. Moore,
J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner,
M. Faggart, et al., The structure of haplotype blocks in the
human genome, Science, vol. 296, no. 5576, pp. 2225–2229,
2002.
[37] J. S. Liu, Monte Carlo Strategies in Scientific Computing,
Berlin, Germany: Springer Science & Business Media,
2008.
[38] G. Casella and E. I. George, Explaining the gibbs sampler,
The American Statistician, vol. 46, no. 3, pp.167–174, 1992.
[39] D. Altshuler and P. Donnelly, A haplotype map of the
human genome, Nature, vol. 437, no. 7063, pp. 1299–1320,
2005.
[40] P. I. de Bakker, R. Yelensky, I. Pe’er, S. B. Gabriel, M. J.
Daly, and D. Altshuler, Efficiency and power in genetic
association studies, Nature Genetics, vol. 37, no. 11, pp.

1217–1223, 2005.
[41] X. Wan, C. Yang, Q. Yang, H. Xue, X. Fan, N. L. Tang,
and W. Yu, Boost: A fast approach to detecting genegene interactions in genome-wide case-control studies,
The American Journal of Human Genetics, vol. 87, no. 3,
pp. 325–340, 2010.
[42] J. Marchini, B. Howie, S. Myers, G. McVean, and
P. Donnelly, A new multipoint method for genome-wide
association studies by imputation of genotypes, Nature
Genetics, vol. 39, no. 7, pp. 906–913, 2007.
[43] X. Guo, Y. Meng, N. Yu, and Y. Pan, Cloud computing for
detecting high-order genome-wide epistatic interaction via
dynamic clustering, BMC Bioinformatics, vol. 15, no. 1,
p. 102, 2014.
[44] J. K. Pritchard and N. A. Rosenberg, Use of unlinked
genetic markers to detect population stratification in
association studies, The American Journal of Human
Genetics, vol. 65, no. 1, pp. 220–228, 1999.

Guanying Wu received the BS and
MS degrees from Peking University
Health Science Center in 2002 and 2004,
respectively. He is now an associate
professor at the Dental Center of ChinaJapan Friendship Hospital. He is a member
of World Society of Lingual Orthodontics,
European Society of Lingual Orthodontics,
World Federation of Orthodontists, Chinese Stomatological
Association, and Beijing Stomatological Association, China. He
has published more than 20 technical papers in various prestigious
journals.

Baohua Xu received the PhD degree from
Peking University Health Science Center
in 1999. He is now a professor at the
Dental Center of China-Japan Friendship
Hospital. He was a visiting professor at
the University of Pennsylvania. He is
also a professor at Beijing University of
Chinese Medicine and Beijing University
of Chemical Technology. He is a member of World Society of
Lingual Orthodontics, European Society of Lingual Orthodontics,
World Federation of Orthodontists, Chinese Stomatological
Association, and Beijing Stomatological Association, China. He
has published more than 20 technical papers in various prestigious
journals.

Xuan Guo received the PhD degree from
Georgia State University in 2015. He is
currently an assistant professor at the
University of North Texas. From 2015
to 2017, he was a postdoctoral research
associate at Oak Ridge National Laboratory.
His research focuses on big data mining
and high-performance computing and their
applications in environment, food, and health sectors. He serves
many premium conferences and journals as editors, chairs, or TPC
members.

